hotspot -WSS

hotspot

author：entertainment 2025-09-30 00:37:24 - browse：3561

Pfizer plans to exit a major biotechnology industry trade association. Cindy Ord/Getty Images for Pfizer/BioNTech

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the planning.

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

“The economic situation for the industry is difficult indeed and we of course are disappointed that any company would be forced to take a break from its BIO membership. We certainly hope that when economic conditions improve, we can welcome those companies back and welcome new members to join us as well, but it in no way affects our mission of protecting patients and medical innovation in the United States,” said BIO’s Chief Public Affairs and Marketing Officer Rich Masters. Masters said he wouldn’t comment on the status of any particular member.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

WSS

Influencer to be charged after chaos erupts in New York City's Union Square

For BCIs, commercial hurdles may be bigger than scientific ones

WuXi Biologics beefs up its lobbying operation

ER docs worry over extreme heat as a 'mass casualty event'

Cherokee Nation medical school graduates its first class

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

hotspot

hotspot

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

The drug industry sees a key ally in the Senate prevail

Wildfire smoke exposes gaps in outdoor worker protections

Attacks on the drug industry will lead to fewer breakthroughs

The cancer drug shortage isn’t new — and neither are the solutions

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Dobbs anniversary: the lost opportunity of abortion as health care

Humana, CVS hope to turn members into patients at clinics

State Dept. review finds Biden bears some blame for Afghanistan failures

A cyberattack has disrupted hospitals and health care in several states

hotspot

Gilgo Beach: Police identify another victim in serial killing investigation

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

The drug industry sees a key ally in the Senate prevail

My superpower is killing ticks

Hottest summer in 2,000 years puts focus on extreme heat, health

What Henrietta Lacks settlement says about racism in medicine

explore

explore

focus

leisure time